Collegium Pharmaceutical Inc (COLL)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 48,155 | -25,002 | 71,517 | 26,752 | -22,722 |
| Total assets | US$ in thousands | 1,143,310 | 1,174,130 | 692,077 | 643,841 | 306,302 |
| ROA | 4.21% | -2.13% | 10.33% | 4.16% | -7.42% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $48,155K ÷ $1,143,310K
= 4.21%
Collegium Pharmaceutical Inc's return on assets (ROA) has demonstrated significant variability over the past five years. In 2023, the ROA improved to 4.21%, indicating that the company generated a profit of 4.21 cents for every dollar of assets. This indicates a positive trend compared to the negative ROA of -2.13% in 2022.
The highest ROA over the period was observed in 2021 at 10.33%, suggesting that the company was more efficient in generating profit from its assets during that year. However, the ROA decreased to 4.16% in 2020 and was negative at -7.42% in 2019, reflecting a less profitable use of assets in those years.
Overall, Collegium Pharmaceutical Inc's ROA fluctuated considerably, indicating varying levels of efficiency in utilizing its assets to generate profits. It is important for investors and stakeholders to monitor this ratio consistently to assess the company's performance and financial health.
Peer comparison
Dec 31, 2023